Risk of vascular disease in women. Smoking, oral contraceptives, noncontraceptive estrogens, and other factors.

We investigated the relation in women of various factors to risk of myocardial infarction, subarachnoid hemorrhage, other strokes, and venous thromboembolism. Smoking significantly increased risk of all four diseases, whereas oral contraceptive use was associated with an increase only in risk of subarachnoid hemorrhage and venous thromboembolism. Use of noncontraceptive estrogens was not associated with increased risk of any of these diseases. Hypertension, hypercholesterolemia, obesity, gallbladder disease, and nondrinking of alcohol were all associated with increased risk of myocardial infarction, whereas only hypertension and hypercholesterolemia were associated with increased risk of other strokes. Cigarette smoking was overwhelmingly the most important risk factor for vascular disease in women. Smoking should be considered a contraindication to oral contraceptive use, or at the very least, women wishing to use oral contraceptives should be strongly urged not to smoke.

[1]  G. Whipple,et al.  Coronary risk and estrogen use in postmenopausal women. , 1978, American journal of epidemiology.

[2]  A Kagan,et al.  Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. , 1976, The New England journal of medicine.

[3]  V. Beral MORTALITY AMONG ORAL-CONTRACEPTIVE USERS Royal College of General Practitioners' Oral Contraception Study , 1977, The Lancet.

[4]  R. Krauss,et al.  Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. , 1978, The New England journal of medicine.

[5]  W. Castelli,et al.  ALCOHOL AND BLOOD LIPIDS The Cooperative Lipoprotein Phenotyping Study , 1977, The Lancet.

[6]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[7]  K. Rothman,et al.  Noncontraceptive estrogens and nonfatal myocardial infarction. , 1978, JAMA.

[8]  K. Rothman,et al.  Oral contraceptives and nonfatal myocardial infarction. , 1978, JAMA.

[9]  D. Petitti,et al.  Oral contraceptives, smoking, and other factors in relation to risk of venous thromboembolic disease. , 1978, American journal of epidemiology.

[10]  W. Kannel,et al.  The epidemiology of gallbladder disease: observations in the Framingham Study. , 1966, Journal of chronic diseases.

[11]  S. van den Noort,et al.  Estrogen use and stroke risk in postmenopausal women. , 1976, American journal of epidemiology.

[12]  D. Petitti,et al.  USE OF ORAL CONTRACEPTIVES, CIGARETTE SMOKING, AND RISK OF SUBARACHNOID HÆMORRHAGE , 1978, The Lancet.

[13]  M. Thorogood,et al.  Myocardial infarction in young women with special reference to oral contraceptive practice. , 1975, British medical journal.

[14]  H. Jick,et al.  Myocardial infarction and estrogen therapy in post-menopausal women. , 1976, The New England journal of medicine.

[15]  Clyne,et al.  Investigation of relation between use of oral contraceptives and thromboembolic disease. , 1968, British medical journal.